Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting: 52-Week Data From the Phase 4 ARTISTYK Study. J of Skin 2025, 9 (6), s649. https://doi.org/10.25251/7j9e8h28.